Biomarkers in Ovarian Cancer: Towards Personalized Medicine

Biomarkers in Ovarian Cancer: Towards Personalized Medicine

Ovarian cancer is one of the deadliest cancers in women. The lack of specific symptoms, especially at the initial stages of disease development, together with the malignancy heterogeneity, lower the life expectancy of patients. Aiming to improve survival rates, diagnostic and prognostic biomarkers a...

Full description

Bibliographic Details
Main Authors: Carlos López-Portugués, María Montes-Bayón, Paula Díez
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Proteomes
Subjects:
ovarian cancer
diagnosis
prognosis
treatment response
biomarkers
cisplatin
Online Access:https://www.mdpi.com/2227-7382/12/1/8

Similar Items

Similar Items